# Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides

> **NCT01026064** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 44 (actual)

## Conditions studied

- Inflammation

## Interventions

- **OTHER:** Cantharidin
- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01026064
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-04
- **Primary completion:** 2009-11-27
- **Final completion:** 2009-11-27
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01026064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01026064, "Cantharidin-induced Skin Blister for Testing Anti-inflammatory Effects of Macrolides". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01026064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*